Home
ACTL Immunotherapy
Functional Mechanism
Advantages
Safety
Indications
Protocols
Steps
Patents
Translational Medicine
Treatment & Prevent
Conditions
Case Studies
Cooperative Hospital
Early Detection
Prevention
Nursing & Care
News
Partnership
About Us
Company Introduction
Our Culture
Milestones
Qualification & Honor
Team of Experts
Activities
Jobs
Contact Us
简体
繁体
英文
Coperate News
Coperate News
Industrial News
Policies & Regulations
09-23 2014
Ishikoning won the "2014 Gold Award for Innovation Achievements in the Biological/Life and Health Industry"
The 2014 Shenzhen International Biological/Life & Health Industry Exhibition was success...
Details
07-26 2013
The 3rd China Conference on Individualized Treatment of Lung Cancer-ACTL Targeted Anti-tumor Immunotherapy
On March 16, 2013, in the early spring morning, the cold in Beijing had not disappeared. Domesti...
Details
04-25 2013
ISKCON and Shenzhen Peking University Hospital conduct academic exchanges on ACTL technology
Professor Liu Yong gave a brief explanation on the current status of tumor bioimmunotherapy at ho...
Details
03-18 2013
The company successfully held the second national autoimmune cell technology seminar
On March 16-17, 2013, ISKCON and the Chinese Medical Doctor Association successfully hel...
Details
11-08 2012
2012 2nd China-Asia Pacific Gynecological Tumor Minimally Invasive Therapy Summit Forum
Dear colleagues: "The 2nd China-Asia Pacific Gynecological Tumor Minimally Invasive Therap...
Details
First
<<
6
7
8
9
10
>>
